Oct 18, 2025
Sensient Announces Conference Call
Oct 17, 2025
Pharmaceutical Contract Manufacturing Global Market Forecast to 2030: Expansion Fueled by Outsourcing for GLP-1, ADC Approvals and Programs, and Loss of Exclusivity for Blockbuster Biologics - ResearchAndMarkets.com
Oct 16, 2025
JFCRx™ Introduces TruPak™ Spark: A Growth-Ready Adherence Pouch Packaging Solution for Pharmacies
Oct 16, 2025
New Roquette Pharmaceutical Innovation Center to Strengthen Latin America as Collaborative Hub
Oct 16, 2025
Aptar Named Among Top 100 of the ‘World’s Top Companies for Women 2025’ by Forbes
Oct 15, 2025
AstraZeneca unveils expanded manufacturing facility in Texas
Oct 15, 2025
PeptiDream, PDRadiopharma and Curium Group Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
Oct 13, 2025
How to Deal with Difficult Situations in GMP (Good Manufacturing Practice) Audits Training Course (Online: March 5, 2026) - ResearchAndMarkets.com
Oct 13, 2025
Enpro Inc. Advances 3.0 Strategy with Agreements to Acquire AlpHa Measurement Solutions and Overlook Industries
Oct 10, 2025
AstraZeneca plans to increase investment and scope of its Virginia manufacturing facility to $4.5 billion, creating 3,600 new jobs
Oct 09, 2025
Nu-Tek BioSciences Highlights Animal-Free Ingredient Advantages at SIMB RAFT 2025
Oct 09, 2025
Braskem Unveils Bio-based Product Innovations at K 2025
Oct 07, 2025
Aphios Corporation Awarded NIH Grant to Advance Botanical Drug Zindol® for Cancer Treatment Related Nausea and Vomiting
Oct 06, 2025
BrightSpec Names Rick Gordon as CEO
Oct 06, 2025
Basil Systems Launches Safety Signaling Solution to Proactively Detect and Prevent Medical Device Risks
Oct 06, 2025
I2Pure Celebrates Zimmer Biomet's Historic Approval of Iodine-Treated Implant System & Confirms AAHKS Attendance
Oct 06, 2025
Mytos Launches Automated CDMO for Scalable, Low-Cost Manufacturing of Stem-Cell Derived Therapies
Oct 04, 2025
$925+ Mn Prefilled Syringe Fill Finish Manufacturing Market Trends and Global Forecasts, 2035 - ResearchAndMarkets.com
Oct 02, 2025
Neuraptive Therapeutics, Inc. Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment of Upper Extremity Transected Nerves Requiring Surgical Repair
Oct 02, 2025
Ideagen Acquires SafetyStratus, Adding Specialized Chemical Management to Its EHS Portfolio